Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

NCT04123470 is registered in ClinicalTrials.gov with Lokon Pharma AB as lead sponsor.

NCT NCT04123470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04123470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Lead sponsor
Lokon Pharma AB
Phase
Phase 1/2
Overall status
Completed
Start date
January 28, 2020
Completion date
July 30, 2023
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma